Not available
Quote | Cesca Therapeutics Inc. (NASDAQ:KOOL)
Last: | $ |
---|---|
Change Percent: | -5.69% |
Open: | $6.45 |
Close: | $6.13 |
High: | $6.45 |
Low: | $5.88 |
Volume: | 101,682 |
Last Trade Date Time: | 10/15/2019 07:28:09 am |
News | Cesca Therapeutics Inc. (NASDAQ:KOOL)
RANCHO CORDOVA, Calif. , Oct. 31, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing for regenerative medicine, today announced that the company will change its name to ThermoGenesis Holdings, Inc. ("ThermoGenesis") in order...
The following slide deck was published by Cesca Therapeutics Inc. in conjunction with this Read more ...
Message Board Posts | Cesca Therapeutics Inc. (NASDAQ:KOOL)
Subject | By | Source | When |
---|---|---|---|
News: $KOOL Cesca Therapeutics Announces Receipt Of $2 | whytestocks | investorshub | 10/02/2019 1:51:19 PM |
News: $KOOL Cesca Therapeutics And ThermoGenesis Announce Major | whytestocks | investorshub | 09/09/2019 2:30:26 PM |
Real News!...https://www.otcmarkets.com/filing/html?id=13632036&guid=YgwfUaJ6H_R | mexico1 | investorshub | 09/07/2019 12:32:49 PM |
News: $KOOL ThermoGenesis Receives Health Canada Approval of | whytestocks | investorshub | 06/18/2019 1:52:10 PM |
Pm popper | Awl416 | investorshub | 06/18/2019 12:33:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Cesca Therapeutics Inc. Company Name:
KOOL Stock Symbol:
NASDAQ Market:
Cesca Therapeutics Inc. Website:
RANCHO CORDOVA, Calif. , Oct. 31, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing for regenerative medicine, today announced that the company will change its name to ThermoGenesis Holdings, Inc. ("ThermoGenesis") in order...
RANCHO CORDOVA, Calif. , Oct. 24, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced Chris Xu , Ph.D., Chairman and Chief Executive Officer, will present a...
RANCHO CORDOVA, Calif. , Oct. 22, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary, today announced that the company...